Call for Abstracts - VPH Research to Business Session

8-9 September 2010, Barcelona, Spain.
The vision of the Virtual Physiological Human is a grand challenge. A key feature of the VPH initiative is the promise of some low-hanging fruits, applications where the power of multiscale simulation technology can be placed into clinical and industrial practices in the not-so-distant future. Viewed in this light, it is essential for all VPH projects to actively disseminate their research results towards the biomedical industry.

For the second year, the VPH Network of Excellence is organising a two-day meeting where the VPH community showcases its best results to the biomedical industry. This is not only to increase the exploitation potential of VPH research, but also to expand the take-on of VPH technologies in the health industry.

This year the program revolves around three types of sessions:

  • Research to Business (R2B), where research consortia present to industry delegates the best results they achieved;
  • Business to Business (B2B), where small and large companies, as well as university spin-offs present products and services that other companies can use to develop other products and services for the final end-user.
  • Regulatory to Business (G2B), where experts of regulatory affair will report on the position of simulation technologies with respect to regulatory affairs.

VPH research projects are invited to participate in this event in three ways:

  • Ensuring that industrial partners of your consortia are informed of the event and are motivated to send delegates
  • Explore with their industrial partners or spin-offs the interest to present their products and services at the B2B session. Those interested should contact Elena Villalba Mora, This email address is being protected from spambots. You need JavaScript enabled to view it..
  • Submit an abstract of the presentation on the best research results they would like to showcase in the R2B session.

Selection Criteria
The draft programme consists of 12 slots of 30-minutes for each presentation. In the event that abstracts received are more than the number of available slots, the organisation of the event will make a selection according to the following criteria:

  • Fair representation of all projects (if two abstracts come from the same project one might be excluded)
  • Broadest possible coverage of the clinical and industrial domains
  • Closeness of results to be presented to the industrial/clinical exploitation

Consortia and research groups who wish to present, should follow the instructions below.

Submission of Abstracts
Your abstract must reach the event organisers no later than the 23rd of April 2010. Selected contributions will be invited for presentation during the 8th and 9th of September 2010.

Instructions for Submission of Abstracts
Please send your abstract to Vanessa Diaz, This email address is being protected from spambots. You need JavaScript enabled to view it. Abstracts will be between 350 and 500 words long, without including the title and the authors. The format is free; feel free to include illustrations.

Abstract Contents
Abstracts should cover the following topics:

  • Subject of research
  • Clinical and/or industrial translation
  • Clinical uptake
  • Development of tools if any

Evaluation
The event organisers will evaluate all abstracts. Notification of acceptance will be provided the last week of April.

For further information, please visit:
http://www.vph-noe.eu

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

  • Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
  • Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
  • Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
  • Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
  • Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
  • Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Finally, by involving clinical and industrial stakeholders, VPH NoE also plans to lay a reliable ground to support sustainable interactions and collaboration between research and healthcare communities.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...